High Prevalence and Diversity of Kidney Dysfunction in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The BARI 2D Baseline Data

被引:16
|
作者
Wall, Barry M. [1 ,2 ]
Hardison, Regina M. [3 ]
Molitch, Mark E. [7 ]
Marroquin, Oscar C. [4 ,5 ,6 ,8 ]
McGill, Janet B. [9 ]
August, Phyllis A. [10 ]
机构
[1] Vet Affairs Med Ctr, Memphis, TN 38104 USA
[2] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
[3] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[4] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[5] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA
[6] Univ Pittsburgh, Div Cardiol, Pittsburgh, PA USA
[7] Northwestern Univ, Med Ctr, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA
[8] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[9] Washington Univ, Dept Med, Div Endocrinol Metab & Lipid Res, Barnes Jewish Hosp, St Louis, MO USA
[10] Weill Cornell Med Coll, Div Nephrol & Hypertens, New York, NY USA
关键词
Diabetes mellitus; Albuminuria; Chronic kidney disease; Clinical epidemiology; Clinical trial; GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; RENAL-INSUFFICIENCY; CARDIOVASCULAR EVENTS; MULTIFACTORIAL INTERVENTION; MICROALBUMINURIA; ALBUMINURIA; RISK; DEATH; INDIVIDUALS;
D O I
10.1097/MAJ.0b013e3181d430ad
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We describe baseline renal function and albumin excretion rate in patients enrolled in Bypass Angioplasty Revascularization Investigation 2 Diabetes, a randomized clinical trial comparing the impact of revascularization and medical therapy with medical therapy alone and deferred or no revascularization and the impact of glycemic control with either insulin-providing or insulin-sensitizing drugs, on 5-year mortality. Methods: Study participants had type 2 diabetes mellitus, documented coronary artery disease, and creatinine <2 mg/dL. Albuminuria status (albumin/creatinine ratio [ACR]) and estimated glomerular filtration rate (eGFR), using the abbreviated Modified Diet in Renal Disease equation, were determined at baseline. Univariate and multivariate relationships between baseline clinical characteristics and the presence of albuminuria and reduced eGFR rate were estimated. Results: Two thousand one hundred forty-six subjects were included in the analysis. Forty-three percent of the cohort had evidence of kidney dysfunction at baseline: 23% had an eGFR >= 60 mL/min/1.73 m(2) with either microalbuminuria (>30 ACR; 17%) or macroalbuminuria (>300 ACR; 6%). Twenty-one percent had a reduced eGFR >= 60 mL/min/1.73 m(2); 52% with reduced eGFR had no albuminuria; 28% had microalbuminuria, and 20% had macroalbuminuria. Race, smoking status, duration of diabetes, hypertension, hemoglobin A1c, triglycerides, vascular disease, abnormal ejection fraction, and reduced eGFR were associated with greater albuminuria. Age, sex, duration of diabetes, ACR, hemoglobin A1c, high density lipoprotein, and number of hypertensive medications were associated with reduced eGFR. Conclusion: Kidney dysfunction is common in older patients with type 2 diabetes mellitus and coronary artery disease; Albuminuria was present in 33%. Reduced eGFR was present in 21%, and half the patients with reduced eGFR had no evidence of albuminuria.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 50 条
  • [21] Prevalence of normoalbuminuric chronic kidney disease among individuals with type 2 diabetes mellitus from India
    Jayakumari, Chellamma
    Gomez, Ramesh
    Dipin, Sasidharan
    Jayakumar, R., V
    Vijayakumar, Karthik
    Sreenath, Ravindranath
    Ajeesh, Thulaseedharan
    Jabbar, Puthiyaveettil Khadar
    Das, Darvin Vamadevan
    Gopi, Giri Vishnu
    Seena, Thadathil Pandarakandy
    Nair, Abilash
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 156 (04) : 632 - 639
  • [22] Endothelial dysfunction in patients with coronary heart disease and Type 2 diabetes mellitus
    Petina, M. M.
    Gorokhovskaya, G. N.
    Martynov, A., I
    RUSSIAN JOURNAL OF CARDIOLOGY, 2011, (02): : 32 - 36
  • [23] Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease
    Kuller, Lewis H.
    CORONARY ARTERY DISEASE, 2010, 21 (07) : 391 - 396
  • [24] Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus
    Farhan, Serdar
    Hochtl, Thomas
    Kautzky-Willer, Alexandra
    Wojta, Johann
    Huber, Kurt
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (1-2) : 30 - 38
  • [25] Screening for asymptomatic coronary artery disease in patients with type 2 diabetes mellitus
    Tavares, Carlos Augusto F.
    Wajchjenberg, Bernardo Leo
    Rochitte, Carlos
    Lerario, Antonio Carlos
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2016, 60 (02): : 143 - 151
  • [26] The vitamin D receptor gene variant is associated with the prevalence of Type 2 diabetes mellitus and coronary artery disease
    Ortlepp, JR
    Lauscher, J
    Hoffmann, R
    Hanrath, P
    Joost, HG
    DIABETIC MEDICINE, 2001, 18 (10) : 842 - 845
  • [27] Importance of Early Screening and Diagnosis of Chronic Kidney Disease in Patients with Type 2 Diabetes
    Skolnik, Neil S.
    Style, Alyssa J.
    DIABETES THERAPY, 2021, 12 (06) : 1613 - 1630
  • [28] Type 2 diabetes mellitus management in patients with chronic kidney disease: an update
    Kleinaki, Zoi
    Kapnisi, Stella
    Theodorelou-Charitou, Sofia-Andriani
    Nikas, Ilias P.
    Paschou, Stavroula A.
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 19 (04): : 467 - 476
  • [29] Albuminuria and chronic kidney disease progression in patients with type 2 diabetes mellitus
    Kawada, Tomoyuki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (10) : 1062 - 1063
  • [30] Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus
    Mortensen, S. B.
    Larsen, S. B.
    Grove, E. L.
    Kristensen, S. D.
    Hvas, A. -M.
    THROMBOSIS RESEARCH, 2010, 126 (04) : E318 - E322